Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Published on by Health Scientists

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Featured Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.

Leticia Peris | Neuroscience | Best Researcher Award

Published on by Health Scientists

Dr. Leticia Peris | Neuroscience | Best Researcher Award 

Inserm researcher | Grenoble Institut of Neurosciences | France

Dr. Leticia Peris is a distinguished neuroscientist and cell biologist whose research focuses on uncovering the molecular mechanisms that regulate the neuronal cytoskeleton and its dysfunction in neurodegenerative diseases. She serves as an Inserm Research Scientist at the Grenoble Institute of Neurosciences (UGA–INSERM U1216, France), where her work has significantly advanced the understanding of tubulin post-translational modifications and their role in neuronal morphogenesis, synaptic integrity, and neurodegeneration. Dr. Peris made pioneering contributions by identifying the tubulin carboxypeptidases VASH1/2–SVBP complex and elucidating their importance in neuronal organization and neurodevelopmental disorders. Her research further demonstrated how dysregulated tubulin modifications contribute to synaptic degeneration in Alzheimer’s disease and revealed new mechanisms of L-Dopa–induced synaptotoxicity in Parkinson’s disease. With an extensive record of publications in high-impact journals, international collaborations, and innovative patents, her work bridges fundamental neuroscience and translational medicine. She actively collaborates with leading researchers across France, Argentina, Germany, and the United States, including teams at Columbia University, Boston Children’s Hospital, and Humboldt University. A member of several international scientific societies and editorial boards, Dr. Peris is also deeply engaged in ethical and ecological initiatives promoting responsible and sustainable scientific practices. Her ongoing projects aim to rejuvenate neuronal cytoskeleton function as a therapeutic strategy against neurodegeneration, making her a leading voice in cellular neurobiology and a key contributor to the global fight against Alzheimer’s and Parkinson’s diseases. She has 2741 citations from 36 documents with an h-index of 24.

Profiles:  Scopus | ORCID

Featured Publications

1. Zorgniotti, A., Sharma, A., Ramirez-Rios, S., Sanyal, C., Aleman, M., Ditamo, Y., Moutin, M. J., Bisig, C. G., & Peris, L. (2024). L-Dopa incorporation into tubulin alters microtubule dynamics and reduces dendritic spine invasion and synapse maintenance [Preprint].

2. Konietzny, A., Han, Y., Popp, Y., van Bommel, B., Sharma, A., Delagrange, P., Arbez, N., Moutin, M. J., Peris, L., & Mikhaylova, M. (2024). Efficient axonal transport of endolysosomes relies on the balanced ratio of microtubule tyrosination and detyrosination. Journal of Cell Science.

3. Konietzny, A., Peris, L., Han, Y., Popp, Y., van Bommel, B., Sharma, A., Delagrange, P., Arbez, N., Moutin, M. J., & Mikhaylova, M. (2023). Efficient axonal trafficking of endolysosomes depends on the balanced ratio of microtubule tyrosination and detyrosination [Preprint].

4. Peris, L. (2022). Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer’s disease. Frontiers in Cell and Developmental Biology.

5. Peris, L. (2022). Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease. Brain: A Journal of Neurology.

Dr. Leticia Peris’s research advances global neuroscience by uncovering cellular mechanisms that drive neurodegenerative diseases, paving the way for innovative therapeutic strategies. Her work bridges fundamental biology and translational medicine, contributing to improved brain health and societal well-being worldwide.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Featured Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.

javad Fahanik babaei | Neuroscience | Best Researcher Award

Published on by Health Scientists

Dr. javad Fahanik babaei | Neuroscience | Best Researcher Award

Faculty member | Tehran University of Medical Sciences | Iran

Dr. Javad Fahanik Babaei is an accomplished Iranian physiologist currently affiliated with the Iran University of Medical Sciences in Tehran, Iran. He earned his Ph.D. in Physiology by research from the same institution in 2018, following an M.Sc. in Developmental Biology (2005) and a B.Sc. in Botany (2003). His extensive research focuses on neurophysiology, electrophysiology, mitochondrial bioenergetics, neurodegeneration, and the pathophysiological mechanisms underlying Alzheimer’s disease and epilepsy. Dr. Babaei has contributed significantly to the understanding of ion channels, synaptic plasticity, and mitochondrial function, with over 40 peer-reviewed publications in prestigious journals such as Biochimica et Biophysica Acta (BBA), Metabolic Brain Disease, Neurophysiology, Journal of Chemical Neuroanatomy, and Scientific Reports. His studies on the electrophysiological and biochemical effects of compounds like trigonelline, apigenin, and riluzole in experimental models of neurodegenerative and epileptic disorders have been widely recognized. Beyond research, he has served as a referee for the Basic and Clinical Neuroscience Journal (2017–2019) and has been a committee member for national physiology and neuroscience congresses in Iran. Dr. Babaei has also contributed to academia as a translator of several foundational physiology and histology textbooks, including Bern and Levy Physiology. His distinguished work in neuroscience and physiology has positioned him as a key contributor to advancing experimental neurobiology in Iran, particularly in the areas of mitochondrial physiology, electrophysiological methodologies, and translational neuroscience research. He has 627 citations from 66 documents with an h-index of 13.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Erratum to “Cognitive impairments induced by repeated sevoflurane exposure during pre-adolescence in adult male and female rats: Involvement of biochemical, histological and neuroplasticity approaches.” (2023). Journal of Cellular and Molecular Anesthesia.

2. Sex-specific behavioral impairments and neuronal alterations in Wistar rats following repeated sevoflurane exposure during developmental stages. (2025). Neurological Research.

3. Protective effects of licofelone on scopolamine-induced spatial learning and memory impairment by enhancing parkin-dependent mitophagy and promotion of neural regeneration in adult mice. (2024). European Journal of Pharmacology.

4. 40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model. (2024). Scientific Reports.

5. Fasudil attenuates lipopolysaccharide-induced cognitive impairment in C57BL/6 mice through anti-oxidative and anti-inflammatory effects: Possible role of aquaporin-4. (2024). IBRO Neuroscience Reports.

Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Assistant Professor | Shahid Beheshti University of Medical Sciences | Iran

Dr. Milad Rahimzadegan is an Assistant Professor at the Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, and serves as R&D Manager in multiple pharmaceutical companies. He earned his PhD in Pharmacy-Toxicology and Pharmacology from Tehran University of Medical Sciences, followed by an M.Sc. in Medical Toxicology from Tarbiat Modares University, and a B.A. in Plant Medicine from the University of Tehran. Recently, he completed a post-doctoral fellowship focused on Artificial Intelligence in Neuroscience at the Functional Neurosurgery Research Center. Dr. Rahimzadegan’s research spans neuropharmacology, neurotoxicology, regenerative medicine, and advanced drug delivery systems, with particular emphasis on stem cell differentiation, conductive scaffolds for spinal cord injury, and nano-biosensing for cardiovascular and neurodegenerative diseases. He has authored numerous high-impact publications in journals including Stem Cell Reviews and Reports, International Journal of Biological Macromolecules, Materials Science & Engineering C, and Carbohydrate Polymers, and has contributed to multiple books on pharmacology, regenerative medicine, and neurosurgery. His work has been recognized with awards such as the Top Academic Secretary of USERN Iran, Young Scientific Award at Shahid Beheshti University, and membership in Iran’s National Elites Foundation. In addition to his research contributions, he serves as a reviewer and editorial board member for journals including Interventional Pain Medicine and Neuromodulation and International Clinical Neuroscience Journal, reflecting his commitment to advancing scientific knowledge and fostering innovation in neuroscience, pharmacology, and translational medicine. He has 326 citations from 26 documents with an h-index of 11.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Rahimzadegan, M., & Soodi, M. (2018). Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus.

2. Asl, S. K., & Rahimzadegan, M. (2022). The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.

3. Malek-Khatabi, A., Razavi, M. S., Abdollahi, A., & Rahimzadeghan, M., et al. (2023). Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery.

4. Asl, S. K., Rahimzadegan, M., & Asl, A. K. (2024). Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

5. Asl, S. K., Rahimzadegan, M., & Ostadrahimi, R. (2024). The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction.